Palouse Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
+2,697
| New | +$1.42M | 0.93% | 49 |
|
|
2024
Q1 | – | Sell |
-1,286
| Closed | -$1.13M | – | 149 |
|
|
2023
Q4 | $1.13M | Sell |
1,286
-8
| -0.6% | -$7.03K | 0.8% | 52 |
|
|
2023
Q3 | $1.06M | Buy |
1,294
+4
| +0.3% | +$3.29K | 0.79% | 54 |
|
|
2023
Q2 | $927K | Sell |
1,290
-76
| -6% | -$54.6K | 0.65% | 59 |
|
|
2023
Q1 | $1.12M | Sell |
1,366
-397
| -23% | -$326K | 0.76% | 55 |
|
|
2022
Q4 | $99.6M | Sell |
1,763
-553
| -24% | -$31.2M | 6.89% | 1 |
|
|
2022
Q3 | $1.6M | Sell |
2,316
-68
| -3% | -$46.8K | 0.91% | 52 |
|
|
2022
Q2 | $1.41M | Sell |
2,384
-601
| -20% | -$355K | 0.7% | 55 |
|
|
2022
Q1 | $2.09M | Sell |
2,985
-118
| -4% | -$82.4K | 0.92% | 50 |
|
|
2021
Q4 | $1.96M | Buy |
3,103
+495
| +19% | +$313K | 0.84% | 50 |
|
|
2021
Q3 | $1.58M | Sell |
2,608
-1,122
| -30% | -$679K | 0.7% | 55 |
|
|
2021
Q2 | $2.08M | Buy |
3,730
+50
| +1% | +$27.9K | 0.91% | 49 |
|
|
2021
Q1 | $1.74M | Buy |
+3,680
| New | +$1.74M | 0.77% | 52 |
|